Phase
Condition
Autism
Asperger's Disorder
Autism Spectrum Disorder (Asd)
Treatment
Melatonin
Clinical Study ID
Ages 12-18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male and female subjects with ASD
12-18 years of age
English speaking
Able to understand and respond to questionnaires in English
Exclusion
Exclusion Criteria:
Pregnant or breastfeeding
Substance abuse or dependence within the past six months (nicotine abuse ordependence is not exclusionary)
Chronic medical conditions that affect sleep
Any unstable chronic medical condition such as asthma, diabetes, cystic fibrosis, orcardiac disease
History of head injury resulting in prolonged loss of consciousness or otherneurological sequelae
IQ <70
Other neurological disorder, including seizure disorder
Diagnosed sleep disorder
Known genetic causes of ASD
Currently taking melatonin or those who have had an adverse reaction to melatonin inthe past
Study Design
Connect with a study center
Massachusetts General Hospital
Boston, Massachusetts 02114
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.